CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 40 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $3,000 | -25.0% | 10 | 0.0% | 0.00% | – |
Q4 2019 | $4,000 | -97.5% | 10 | -98.1% | 0.00% | – |
Q3 2019 | $163,000 | +21.6% | 517 | 0.0% | 0.00% | – |
Q2 2019 | $134,000 | -72.7% | 517 | +13.9% | 0.00% | – |
Q1 2019 | $490,000 | -37.6% | 454 | 0.0% | 0.00% | – |
Q4 2018 | $785,000 | -70.2% | 454 | 0.0% | 0.00% | – |
Q3 2018 | $2,633,000 | +35.5% | 454 | 0.0% | 0.00% | – |
Q2 2018 | $1,943,000 | -94.2% | 454 | -92.0% | 0.00% | – |
Q1 2018 | $33,242,000 | +28.1% | 5,663 | +0.8% | 0.00% | – |
Q4 2017 | $25,960,000 | +89.4% | 5,619 | +125.1% | 0.00% | – |
Q3 2017 | $13,703,000 | -11.3% | 2,496 | -6.9% | 0.00% | – |
Q2 2017 | $15,443,000 | – | 2,681 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|